An application of random forest regression for predicting healthcare costs using administrative databases.

IF 2.2 4区 医学 Q3 HEALTH CARE SCIENCES & SERVICES
Isabella Sala, Sara Conti, Ippazio C Antonazzo, Lorenzo Losa, Pietro Ferrara, Davide Rozza, Carla Fornari, Giacomo Crotti, Giuseppe Sampietro, Alberto Zucchi, Vincenzo Bagnardi, Lorenzo G Mantovani
{"title":"An application of random forest regression for predicting healthcare costs using administrative databases.","authors":"Isabella Sala, Sara Conti, Ippazio C Antonazzo, Lorenzo Losa, Pietro Ferrara, Davide Rozza, Carla Fornari, Giacomo Crotti, Giuseppe Sampietro, Alberto Zucchi, Vincenzo Bagnardi, Lorenzo G Mantovani","doi":"10.1080/14737167.2026.2738028","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Accurate healthcare cost predictions are essential for health economic decision-making. We propose a bottom-up approach that aggregates individual-level predictions to estimate expenditures for specific population segments without relying on <i>a priori</i> segmentation.</p><p><strong>Methods: </strong>This retrospective population-based study used administrative healthcare data (2011-2023) from the Health Protection Agency of Bergamo (Italy). We traced 5-year healthcare resource utilization to predict individual's healthcare costs in the following year using random forest regression algorithms. Individual predictions were aggregated to derive mean per-capita cost estimates for the overall population and selected high-impact subgroups. Performance was assessed at the individual-level using error metrics, and at the population-level using prediction error (PE).</p><p><strong>Results: </strong>At the individual-level, algorithms had a poor performance, systematically underestimating high-cost users. However, aggregated predictions were reliable. For the overall population, pre-pandemic PEs ranged from -2.5% to -0.4% and stabilized by 2023 (PE = -0.7%), after 2020-2021 volatility. In high-impact groups, dialysis and diabetic patients showed consistent PE temporal trends not exceeding -10%. Other segments exhibited more marked underestimations, with PE reaching -30%.</p><p><strong>Conclusion: </strong>Machine learning-based bottom-up approach applied to administrative databases demonstrated potential for population-level public healthcare expenditure forecasting within the geographical context of this study. These findings support further evaluation of this approach for budget planning and health economic applications, while external validation across different areas and administrative settings will be necessary to assess its generalizability.</p>","PeriodicalId":12244,"journal":{"name":"Expert Review of Pharmacoeconomics & Outcomes Research","volume":" ","pages":"1-14"},"PeriodicalIF":2.2000,"publicationDate":"2026-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Expert Review of Pharmacoeconomics & Outcomes Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/14737167.2026.2738028","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Accurate healthcare cost predictions are essential for health economic decision-making. We propose a bottom-up approach that aggregates individual-level predictions to estimate expenditures for specific population segments without relying on a priori segmentation.

Methods: This retrospective population-based study used administrative healthcare data (2011-2023) from the Health Protection Agency of Bergamo (Italy). We traced 5-year healthcare resource utilization to predict individual's healthcare costs in the following year using random forest regression algorithms. Individual predictions were aggregated to derive mean per-capita cost estimates for the overall population and selected high-impact subgroups. Performance was assessed at the individual-level using error metrics, and at the population-level using prediction error (PE).

Results: At the individual-level, algorithms had a poor performance, systematically underestimating high-cost users. However, aggregated predictions were reliable. For the overall population, pre-pandemic PEs ranged from -2.5% to -0.4% and stabilized by 2023 (PE = -0.7%), after 2020-2021 volatility. In high-impact groups, dialysis and diabetic patients showed consistent PE temporal trends not exceeding -10%. Other segments exhibited more marked underestimations, with PE reaching -30%.

Conclusion: Machine learning-based bottom-up approach applied to administrative databases demonstrated potential for population-level public healthcare expenditure forecasting within the geographical context of this study. These findings support further evaluation of this approach for budget planning and health economic applications, while external validation across different areas and administrative settings will be necessary to assess its generalizability.

使用管理数据库预测医疗保健费用的随机森林回归应用。
背景:准确的医疗成本预测对卫生经济决策至关重要。我们提出了一种自下而上的方法,汇总个人层面的预测来估计特定人群的支出,而不依赖于先验分割。方法:这项基于人群的回顾性研究使用了意大利贝加莫健康保护局(Health Protection Agency of Bergamo) 2011-2023年的行政保健数据。我们追踪了5年的医疗资源利用情况,使用随机森林回归算法预测个人在接下来一年的医疗费用。汇总个人预测,得出总体人口和选定的高影响亚群体的平均人均成本估算。在个人水平上使用误差指标评估绩效,在总体水平上使用预测误差(PE)评估绩效。结果:在个体层面,算法表现不佳,系统性低估了高成本用户。然而,综合预测是可靠的。对于总体人口,大流行前的PE在-2.5%至-0.4%之间,在经历了2020-2021年的波动之后,到2023年趋于稳定(PE = -0.7%)。在高影响组中,透析和糖尿病患者表现出一致的PE时间趋势,不超过-10%。其他细分市场表现出更明显的低估,PE达到-30%。结论:应用于行政数据库的基于机器学习的自下而上方法显示了在本研究的地理背景下预测人口水平公共医疗保健支出的潜力。这些发现支持进一步评价这一方法在预算规划和卫生经济应用方面的作用,同时需要在不同领域和行政环境中进行外部验证,以评估其普遍性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Expert Review of Pharmacoeconomics & Outcomes Research
Expert Review of Pharmacoeconomics & Outcomes Research HEALTH CARE SCIENCES & SERVICES-PHARMACOLOGY & PHARMACY
CiteScore
4.00
自引率
4.30%
发文量
68
审稿时长
6-12 weeks
期刊介绍: Expert Review of Pharmacoeconomics & Outcomes Research (ISSN 1473-7167) provides expert reviews on cost-benefit and pharmacoeconomic issues relating to the clinical use of drugs and therapeutic approaches. Coverage includes pharmacoeconomics and quality-of-life research, therapeutic outcomes, evidence-based medicine and cost-benefit research. All articles are subject to rigorous peer-review. The journal adopts the unique Expert Review article format, offering a complete overview of current thinking in a key technology area, research or clinical practice, augmented by the following sections: Expert Opinion – a personal view of the data presented in the article, a discussion on the developments that are likely to be important in the future, and the avenues of research likely to become exciting as further studies yield more detailed results Article Highlights – an executive summary of the author’s most critical points.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书